These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 29361177
1. Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis. Fernandes Costa A, Evangelista Araujo D, Santos Cabral M, Teles Brito I, Borges de Menezes Leite L, Pereira M, Correa Amaral A. Med Mycol; 2019 Jan 01; 57(1):52-62. PubMed ID: 29361177 [Abstract] [Full Text] [Related]
2. Miconazole loaded chitosan-based nanoparticles for local treatment of vulvovaginal candidiasis fungal infections. Amaral AC, Saavedra PHV, Oliveira Souza AC, de Melo MT, Tedesco AC, Morais PC, Soares Felipe MS, Bocca AL. Colloids Surf B Biointerfaces; 2019 Feb 01; 174():409-415. PubMed ID: 30481701 [Abstract] [Full Text] [Related]
3. Fluconazole and propolis co-encapsulated in chitosan nanoparticles for the treatment of vulvovaginal candidiasis in a murine model. da Silva JT, Dantas de Sousa PH, Costa AF, de Menezes LB, Alves SF, Pellegrini F, Amaral AC. Med Mycol; 2023 Nov 06; 61(11):. PubMed ID: 37947253 [Abstract] [Full Text] [Related]
4. Chitosan nanoparticles encapsulating farnesol evaluated in vivo against Candida albicans. Costa AF, da Silva JT, Martins JA, Rocha VL, de Menezes LB, Amaral AC. Braz J Microbiol; 2024 Mar 06; 55(1):143-154. PubMed ID: 37964169 [Abstract] [Full Text] [Related]
5. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis. Gao M, Wang H, Zhu L. Cell Physiol Biochem; 2016 Mar 06; 40(3-4):727-742. PubMed ID: 27915337 [Abstract] [Full Text] [Related]
7. [Study on classification and treatment of vulvovaginal candidiasis]. Fan SR, Liu XP, Li JW, Xu AP, Liu M. Zhonghua Fu Chan Ke Za Zhi; 2005 Aug 01; 40(8):532-5. PubMed ID: 16202291 [Abstract] [Full Text] [Related]
8. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model. Bozó A, Domán M, Majoros L, Kardos G, Varga I, Kovács R. J Microbiol; 2016 Nov 01; 54(11):753-760. PubMed ID: 27796932 [Abstract] [Full Text] [Related]
9. Plasma-based strategy for inhibiting Candida albicans growth and CaMCA1 gene expression in vitro and reducing fungal pathogenicity in a murine model of vulvovaginal candidiasis. Ebrahimi-Shaghaghi F, Atyabi SM, Razzaghi-Abyaneh M. Med Mycol; 2021 Dec 08; 60(1):. PubMed ID: 34694384 [Abstract] [Full Text] [Related]
10. The effects of miconazole on the ultrastructure of Candida albicans. De Nollin S, Borgers M, Van Belle H. Proc R Soc Med; 1977 Dec 08; 70 Suppl 4(Suppl 4):19-23. PubMed ID: 122689 [No Abstract] [Full Text] [Related]
12. Investigation of thiosemicarbazide free or within chitosan nanoparticles in a murine model of vulvovaginal candidiasis. Araújo DE, de Oliveira AA, Cabral MDS, Costa AF, Silva BC, do Carmo Silva L, de Menezes LB, de Almeida Soares CM, Amaral AC, Pereira M. Braz J Microbiol; 2020 Dec 08; 51(4):1465-1473. PubMed ID: 32638273 [Abstract] [Full Text] [Related]
13. Chitosan-coated miconazole as an effective anti-inflammatory agent for the treatment of postoperative infections in obstetrics and vaginal yeast infection control on in vitro evaluations. Shi L, Xu S, Zhu Q, Wei Y. Microb Pathog; 2023 Nov 08; 184():106312. PubMed ID: 37652266 [Abstract] [Full Text] [Related]
14. Exploring the Biofilm Inhibition Potential of a Novel Phytic Acid-Crosslinked Chitosan Nanoparticle: In Vitro and In Vivo Investigations. Nayak R, Rai VK, Pradhan D, Halder J, Rajwar TK, Dash P, Das C, Mishra A, Mahanty R, Saha I, Manoharadas S, Kar B, Ghosh G, Rath G. AAPS PharmSciTech; 2024 May 09; 25(5):106. PubMed ID: 38724834 [Abstract] [Full Text] [Related]
15. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E. Akush Ginekol (Sofiia); 2016 May 09; 55(4):20-29. PubMed ID: 29370489 [Abstract] [Full Text] [Related]
16. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B. Ludwig DB, de Camargo LEA, Khalil NM, Auler ME, Mainardes RM. Mycopathologia; 2018 Aug 09; 183(4):659-668. PubMed ID: 29497926 [Abstract] [Full Text] [Related]
17. Problems in the laboratory assessment of antifungal activity. Odds FC. Postgrad Med J; 1979 Sep 09; 55(647):677-80. PubMed ID: 392483 [Abstract] [Full Text] [Related]
18. [Inhibitory effects of butyl alcohol extract of Baitouweng decoction on yeast-to-hyphae transition of Candida albicans isolates from VVC in alkaline pH environment]. Zhang MX, Xia D, Shi GX, Shao J, Wang TM, Tang CC, Wang CZ. Zhongguo Zhong Yao Za Zhi; 2015 Feb 09; 40(4):710-5. PubMed ID: 26137695 [Abstract] [Full Text] [Related]
19. Transdermal administration of farnesol-ethosomes enhances the treatment of cutaneous candidiasis induced by Candida albicans in mice. Shen T, Tian B, Liu W, Yang X, Sheng Q, Li M, Wang H, Wang X, Zhou H, Han Y, Ding C, Sai S. Microbiol Spectr; 2024 Apr 02; 12(4):e0424723. PubMed ID: 38415658 [Abstract] [Full Text] [Related]
20. Nanoparticulated Systems Based on Natural Polymers Loaded with Miconazole Nitrate and Lidocaine for the Treatment of Topical Candidiasis. Tejada G, Barrera MG, García P, Sortino M, Lamas MC, Lassalle V, Alvarez V, Leonardi D. AAPS PharmSciTech; 2020 Oct 08; 21(7):278. PubMed ID: 33033939 [Abstract] [Full Text] [Related] Page: [Next] [New Search]